drugset / Trial / NCT04505436
Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is a phase 2 study to Evaluate Efficacy, Safety and Tolerability of HM15211 Treatment for 12 Months in Subjects with Biopsy Confirmed NASH
Timeline
- Start
- 2020-07-31
- Primary completion
- 2026-06-27
- Completion
- 2026-07-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Efocipegtrutide | Protein / enzyme biologic | — | — |